In this video, Paul A. Calvo, Ph.D. discusses the success of generic biologic manufacturers at the FDA and in the courts as the era of generic biologic drugs has officially begun. Dr. Calvo examines the first two biosimilar applications filed with the FDA, the first court activity pertaining to biosimilars, and the FDA's recently released Purple Book.